Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.330
+0.040 (1.75%)
At close: Mar 13, 2026, 4:00 PM EDT
2.410
+0.080 (3.43%)
After-hours: Mar 13, 2026, 6:47 PM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $294.29 million as of March 13, 2026. Its market cap has increased by 99.39% in one year.
Market Cap
294.29M
Enterprise Value
220.90M
1-Year Change
99.39%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $294.29M, an increase of 151.45%. That is a compound annual growth rate of 20.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 294.90M | 19.73% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | 117.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XOMA Royalty | 320.51M |
| Avalo Therapeutics | 316.57M |
| Minerva Neurosciences | 315.90M |
| Cabaletta Bio | 314.79M |
| Prelude Therapeutics | 313.93M |
| Puma Biotechnology | 305.26M |
| Protara Therapeutics | 302.87M |
| AC Immune | 302.77M |